Skip to content

    KYNTRA BIO (KYNB) stock price & financials

    View KYNB earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance23.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $123.0K
    $3.14M
    $2.74M
    $1.35M
    $1.08M
    +774.8%
    $1.28M
    -59.3%
    $3.74M
    +36.5%
    -$1.47M
    -209.3%
    Weakening
    Operating Profit
    -$47.69M
    -$7.13M
    -$14.92M
    -$12.05M
    -$5.41M
    +88.7%
    -$13.51M
    -89.4%
    -$13.82M
    +7.4%
    -$17.57M
    -45.8%
    Weakening
    Net Profit
    -$17.08M
    $17.98M
    $4.64M
    -$7.60M
    $200.64M
    -$14.22M
    -179.1%
    -$15.20M
    -427.6%
    $11.97M
    Weakening
    EPS
    $-4.25
    $1.15
    $-1.88
    $49.61
    $-3.76
    -427.0%
    $2.96
    Weakening
    Other Income
    $1.47M
    $689.0K
    $413.0K
    $286.0K
    $931.0K
    -36.8%
    $1.31M
    +90.6%
    $1.11M
    +169.5%
    $975.0K
    +240.9%
    Strengthening
    Interest
    $2.07M
    $2.22M
    $2.26M
    $2.01M
    $2.08M
    +0.7%
    $2.41M
    +8.7%
    $2.43M
    +7.5%
    $2.37M
    +17.9%
    Strengthening
    Depreciation
    Profit before Tax
    -$48.29M
    -$8.66M
    -$16.76M
    -$13.78M
    -$13.15M
    +72.8%
    -$14.61M
    -68.6%
    -$15.13M
    +9.7%
    $11.97M
    Weakening
    MarginsOPM
    -38774.0%
    -227.5%
    -544.7%
    -894.1%
    -502.9%
    +98.7%
    -1058.1%
    -365.1%
    -369.7%
    +32.1%
    1192.3%
    Weakening
    Tax
    -0.0%
    -0.0%
    -0.0%
    0.7%
    0.0%
    +100.0%
    0.0%
    +100.0%
    0.0%
    +100.0%
    -0.0%
    -101.5%
    Strengthening
    ReturnsROIC
    1.0%
    -1.1%
    -0.3%
    0.4%
    -11.7%
    -1274.4%
    0.8%
    0.9%
    -0.7%
    -257.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$89.26M$126.27M$678.39M$171.22M$155.70M$81.55M$50.48M$47.87M$50.64M
    Short-Term Investments
    Total Current Assets$690.01M$702.49M$755.11M$474.06M$492.83M$331.56M$196.51M$99.07M$96.83M
    Net PP&E$127.20M$44.67M$35.69M$119.39M$100.50M$69.72M$0
    Goodwill
    Intangibles
    Total Assets$880.60M$857.40M$826.84M$773.82M$610.09M$423.53M$214.53M$119.59M$101.08M
    LiabilitiesTotal Current Liabilities$89.03M$102.75M$163.19M$225.50M$273.56M$217.67M$133.31M$29.24M$36.04M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$942.0K$853.0K$88.78M$79.59M$65.03M$0
    Total Liabilities$352.13M$321.99M$385.39M$544.71M$611.57M$585.73M$398.16M$115.12M$109.22M
    EquityCommon Stock & APIC$854.0K$877.0K$914.0K$929.0K$942.0K$988.0K$1.01M$1.01M$41.0K
    Retained Earnings-$715.83M-$784.72M-$974.01M-$1.26B-$1.56B-$1.84B-$1.89B-$1.71B-$1.71B
    Total Equity$509.20M$516.13M$422.18M$209.15M-$21.45M-$204.17M-$225.60M-$30.04M-$30.14M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$76.14M-$78.70M$81.60M-$82.23M-$145.93M-$315.02M-$138.00M-$4.77M-$38.05M
    Cash from Investing-$522.12M$120.02M$452.49M-$426.97M$89.12M$153.66M$125.99M$35.42M$56.14M
    Cash from Financing$13.88M-$4.30M$13.34M-$563.0K$46.78M$122.75M-$255.0K-$86.03M-$85.94M
    SummaryCapital Expenditure-$8.02M-$5.76M-$3.99M-$5.19M-$3.74M-$2.52M-$266.0K-$38.0K-$9.0K
    Free Cash Flow-$84.16M-$84.47M$77.61M-$87.42M-$149.67M-$317.54M-$138.26M-$4.81M-$38.06M
    FCF Margin-39.5%-32.9%44.0%-37.2%-106.4%-678.5%-466.8%-74.7%-824.4%

    Ratios